---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-011197"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-04-02T23:59:59+00:00"
generated_at: "2026-05-24T00:05:34.087809+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals reports Series B Preferred conversions into 287,467 common shares

## Summary
- Three holders converted 392 Series B Preferred shares (aggregate stated value $431,200) at $1.50/share.
- Total common shares issued: 287,467, diluting existing shareholders per preferred terms.
- Exemption claimed under Securities Act Section 3(a)(9) for exchange with existing holders.

## SEC filing metadata
- accession: 0001493152-25-011197
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225011197/0001493152-25-011197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225011197/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-011197
- JSON: https://secwatch.observer/filing/0001493152-25-011197.json
- Plain text: https://secwatch.observer/filing/0001493152-25-011197.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.